Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROPHENO: Phenobarbital Prophylaxis for Neonatal Seizures
NCT01089504Phase 4Terminated
- Sponsor
- University of Rochester
- Start
- Sep 2010
- Primary completion
- Nov 2014
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of phenobarbital in neonatal seizures, sponsored by University of Rochester. Started Sep 2010; status: terminated.
02
Drugs
phenobarbital
03
Conditions
neonatal seizures
Beyond the preview
Go deeper on NCT01089504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01089504.